11.75
Schlusskurs vom Vortag:
$11.53
Offen:
$11.47
24-Stunden-Volumen:
826.94K
Relative Volume:
1.40
Marktkapitalisierung:
$765.35M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-112.51M
KGV:
-7.7815
EPS:
-1.51
Netto-Cashflow:
$-96.01M
1W Leistung:
+6.82%
1M Leistung:
-7.63%
6M Leistung:
-10.78%
1J Leistung:
+32.77%
Zymeworks Inc. Stock (ZYME) Company Profile
Firmenname
Zymeworks Inc.
Sektor
Branche
Telefon
604-678-1388
Adresse
1385 West 8th Avenue, Suite 540, Vancouver, BC
Vergleichen Sie ZYME mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ZYME
Zymeworks Inc.
|
11.75 | 765.35M | 62.71M | -112.51M | -96.01M | -1.51 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-16 | Hochstufung | JP Morgan | Neutral → Overweight |
2024-11-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2024-11-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2023-03-21 | Fortgesetzt | Wells Fargo | Overweight |
2023-01-04 | Bestätigt | H.C. Wainwright | Neutral |
2022-12-20 | Hochstufung | Jefferies | Hold → Buy |
2022-11-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
2022-05-05 | Hochstufung | Guggenheim | Neutral → Buy |
2022-03-15 | Eingeleitet | Evercore ISI | Outperform |
2021-12-10 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2021-11-17 | Fortgesetzt | Guggenheim | Neutral |
2021-10-07 | Eingeleitet | Jefferies | Hold |
2021-03-31 | Eingeleitet | Credit Suisse | Outperform |
2021-02-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2021-02-08 | Fortgesetzt | H.C. Wainwright | Buy |
2021-01-25 | Herabstufung | Citigroup | Buy → Neutral |
2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
2020-08-06 | Eingeleitet | SVB Leerink | Outperform |
2020-01-10 | Eingeleitet | Wolfe Research | Outperform |
2019-12-09 | Eingeleitet | JP Morgan | Neutral |
2019-11-25 | Eingeleitet | H.C. Wainwright | Buy |
2019-11-20 | Eingeleitet | Guggenheim | Buy |
2019-09-30 | Hochstufung | Raymond James | Outperform → Strong Buy |
2019-08-30 | Eingeleitet | Stifel | Buy |
2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
2018-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
2018-03-19 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - The Financial World
Zymeworks appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - MediaNews4U
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment - TipRanks
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development | ZYME Stock News - GuruFocus
Zymeworks Strengthens Cancer Drug Pipeline: Top Oncology Expert Takes Helm of Clinical Development - Stock Titan
Major Investment Alert: Ecor1 Capital Boosts Stake in Zymeworks! - TipRanks
Zymeworks to Announce Q1 2025 Financial Results and Host Conference Call - TipRanks
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 | ZYME Stock News - GuruFocus
Zymeworks Inc. to Announce First Quarter 2025 Financial Results on May 8, 2025 - Nasdaq
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewswire
Clinical-Stage Biotech Zymeworks Sets Q1 2025 Earnings Date: Key Updates Expected - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Yahoo Finance
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
Zymeworks sees $3.62 million stock purchase by EcoR1 Capital - Investing.com Canada
Zymeworks Announces Participation in Upcoming Investor Conferences, Business Wires News - AsiaOne
Zymeworks Inc. sees insider purchases totaling $1.5 million By Investing.com - Investing.com South Africa
Major Investment Alert: Director Buys Big in Zymeworks! - TipRanks
Zymeworks Inc. sees insider purchases totaling $1.5 million - Investing.com
Ecor1 Capital, Llc Purchases 22,689 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat
Major Investment Alert: Ecor1 Capital Buys Big in Zymeworks! - TipRanks
Ecor1 Capital’s Oleg Nodelman buys $1.23 million in Zymeworks stock By Investing.com - Investing.com Canada
Zymeworks to Engage Investors at Upcoming Conferences - TipRanks
Zymeworks Announces Participation in Upcoming Investor Conferences - The Manila Times
Clinical-Stage Biotech Zymeworks Reveals New Pipeline Insights at Two Major Healthcare Conferences - Stock Titan
Zymeworks to Present Promising Cancer Therapy Data at AACR Meeting - TipRanks
Zymeworks to Present Preclinical Data on T cell Engager and - GlobeNewswire
Game-Changing Cancer Drug Results: Zymeworks Reveals 6 Promising Treatments at AACR - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Receiving the Most Insider Love in March - Insider Monkey
EcoR1 Capital, LLC Increases Stake in Zymeworks Inc - GuruFocus
Zymeworks Inc. sees $1.64 million stock purchase by EcoR1 Capital - Investing.com Philippines
EcoR1 Capital, LLC's Strategic Acquisition of Zymeworks Inc Shar - GuruFocus
What is Leerink Partnrs’ Forecast for Zymeworks Q1 Earnings? - The AM Reporter
Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey
Zymeworks sees over $2.8 million in stock purchases by EcoR1 Capital - Investing.com Australia
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Consensus PT from Brokerages - Defense World
Q1 Earnings Estimate for Zymeworks Issued By Lifesci Capital - Defense World
EcoR1 capital acquires $13.1 million in Zymeworks stock By Investing.com - Investing.com South Africa
EcoR1 capital acquires $13.1 million in Zymeworks stock - Investing.com India
Equities Analysts Issue Forecasts for Zymeworks Q1 Earnings - Defense World
Finanzdaten der Zymeworks Inc.-Aktie (ZYME)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):